JUVÉDERM is the only
hyaluronic acid dermal filler developed using a proprietary, technologically
advanced manufacturing process that results in a malleable smooth gel that flows
easily into the skin, creating a smooth, natural look and feel. All other
currently approved hyaluronic acid dermal fillers utilize a gel particle
suspension formulation. These gel particles can be visibly seen as opposed to
the smoother formulation used in JUVÉDERM dermal filler.
In addition, JUVÉDERM
contains the highest concentration of non-animal, cross-linked hyaluronic acid
of any dermal filler currently available. These unique attributes provide
optimal results with a single treatment in the majority of patients and deliver
sustained results for up to six months or longer.
JUVÉDERM dermal filler is natural,
biodegradable and currently the only hyaluronic acid dermal filler that has
demonstrated its safety and effectiveness in patients of all skin types and
It demonstrated no increased risk
of hyperpigmentation or hypertrophic scarring in patients of color.
This dermal filler can be
administered in a smooth-flowing injection, providing physicians with a high
level of control for individualized, tailored facial contouring and for
achieving a smooth and natural look.
The active ingredient in JUVÉDERM™ dermal filler,
hyaluronic acid, is a naturally occurring,
biodegradable complex sugar found in the human body
and in all living organisms. Among other things,
hyaluronic acid hydrates the skin and adds volume,
contributing to the overall appearance of the skin.
Like BOTOX® (Botulinum Toxin Type A), which has been
available for more than 16 years and is approved to
treat 20 conditions in more than 75 countries around
the world, hyaluronic acid has been used for more
than 20 years to treat multiple medical conditions,
including those associated with the eye and the
The ability of cells to produce hyaluronic acid
diminishes with age, often resulting in the
formation of facial wrinkles and folds as the skin
loses volume. JUVÉDERM™ is administered in small
doses by intradermal injection directly into facial
wrinkles and folds, such as nasolabial folds (the
folds running from the sides of the bottom of the
nose to the outer corners of the mouth), temporarily
filling and augmenting the treated area.
BOTOX® Cosmetic works differently -- by relaxing the
dominant frown muscles between the eyebrows (the
glabellar area). This allows the two vertical lines
between the brows, often referred to as the “11,” to
temporarily diminish in appearance. BOTOX® Cosmetic
was approved by the FDA in 2002 for the temporary
improvement in the appearance of moderate to severe
frown lines between the brows in people 18 to 65
years of age.
Post Op Instructions l